TP53 and small cell lung carcinoma: Taken together with our recent studies showing that Rlip depletion in Tp53−/− mice nearly completely prevents the hypomethylation of the promoters of many stem cell genes [28], suggest that 2HF could overcome cancer stem-cell mediated therapy resistance of p53-mutated SCLC.